Financials

News Discussions Technicals Seasonals

8622 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Huakang Biomedical Holdings Co. Ltd. operates as a medical group company. The firm engages in the manufacture and sale of in-vitro diagnostic (IVD) reagents in China. Its product portfolio of IVD reagents consists of male fertility IVD reagents, parasite antibody detection reagents and an EBV antibody detection reagent. The company was founded on August 3, 2017 and is headquartered in Kowloon, Hong Kong.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

8622 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company